Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$19,490,021
+$2,874,003 QoQ
Shares Held
77,452
+1.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#620
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penobscot Investment Management Company, Inc. holds $78,402,280 across 11 Drug Manufacturers - General names. ABBV ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
77,452 | $19,490,021 | |
| 2 | LLY |
ELI LILLY & Co
|
12,634 | $15,153,599 | |
| 3 | JNJ |
Johnson & Johnson
|
55,938 | $14,206,573 | |
| 4 | AZN |
Astrazeneca PLC
|
60,174 | $11,410,193 | |
| 5 | AMGN |
Amgen Inc
|
16,503 | $5,976,066 | |
| 6 | NVS |
Novartis AG
|
26,577 | $4,165,147 | |
| 7 | MRK |
Merck & Co., Inc.
|
31,382 | $4,032,587 | |
| 8 | PFE |
Pfizer Inc
|
79,410 | $1,912,192 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,490,021 | 77,452 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $16,616,018 | 76,399 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $17,611,095 | 77,076 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $17,766,295 | 76,731 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $14,148,513 | 76,223 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $16,296,465 | 77,780 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $13,763,398 | 77,453 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,198,455 | 76,962 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,061,761 | 76,153 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $13,547,875 | 74,398 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,579,048 | 74,718 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $11,021,942 | 73,943 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,769,540 | 72,512 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $11,595,122 | 72,756 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $11,702,179 | 72,410 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,759,884 | 72,721 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $11,141,011 | 72,741 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,735,142 | 72,390 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $9,896,114 | 73,088 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,259,821 | 76,572 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $8,601,978 | 76,367 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $8,309,889 | 76,787 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $8,327,375 | 77,717 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $6,819,932 | 77,862 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $7,655,486 | 77,974 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $6,026,171 | 79,094 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||